This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Profit From 5 Trades Warren Buffett Made

Stocks in this article: XOMSUCOPGSKDVA

DaVita HealthCare Partners

Enough about energy. DaVita HealthCare Partners ( DVA) is another name that should sound familiar to Buffett disciples. And the Oracle of Omaha is buying more in 2013. Berkshire Hathaway added 1.5 million shares to its portfolio in the latest quarter, boosting its total stake to $1.79 billion.

>>5 Toxic Stocks to Sell Before It's Too Late

DaVita operates more than 1,850 dialysis clinics and in-patient hospital dialysis units across the U.S., serving patients who suffer from chronic kidney failure. The long-term nature of dialysis treatment makes DVA's business pretty predictable, since kidney transplants are scare. DaVita has been cautious about its relationship with Buffett's firm -- the two parties agreed to a deal in May that limits Berkshire Hathaway's ownership of DVA to 25%. The latest trade brings the DVA stake to 14.8%.

A $4.4 billion merger with HealthCare Partners changed DVA's business dramatically in the past year, putting medical practices, hospitals, and pharmacy services under DVA's umbrella for a 25% contribution to corporate revenues. But none of that changes the fact that DVA trades for a premium right now. While demographic tailwinds should keep a steady stream of patients at DVA's doors, much of that upside is already priced into shares.

5 of 6

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,810.06 +91.06 0.51%
S&P 500 2,063.50 +10.75 0.52%
NASDAQ 4,712.97 +11.1030 0.24%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs